logo
AI Icon𝛼SK or Search
ENTITY

Shenzhen Immunofoco (2633140D HK)

4
Analysis
Health Care • China
Shenzhen Immunofoco Biotechnology Co., Ltd. develops innovative cell therapies. The Company produces anti-CLDN18.2 CAR-T cell therapy candidate (IMC002) for treatment of solid tumors and anti-EpCAM CAR-T cell therapy candidate (IMC001). Shenzhen Immunofoco Biotechnology conducts businesses in China.
more
Publication Icon
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.
Back to "All"

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x